Bionik Laboratories (OTCMKTS:BNKL) Stock Price Passes Above 50-Day Moving Average – Time to Sell?

Bionik Laboratories Corp. (OTCMKTS:BNKL – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0001. Bionik Laboratories shares last traded at $0.00, with a volume of 0 shares changing hands.

Bionik Laboratories Price Performance

Get Bionik Laboratories alerts:

About Bionik Laboratories

(Get Free Report)

Bionik Laboratories Corp., headquartered in Waltham, Massachusetts, designs, develops and markets robotics-based rehabilitation solutions and assistive devices for patients with neurological and mobility impairments. Its core product portfolio includes the ARKE lower limb exoskeleton for gait training and the InMotion series of upper extremity robotic therapy devices, such as InMotion ARM and InMotion WRIST. These systems leverage sensor-driven feedback and proprietary software to enable clinicians to deliver personalized motor rehabilitation programs.

Founded in 2008, Bionik established a foundation in exoskeleton and robotics technology before expanding its clinical product suite through strategic acquisitions and research collaborations.

Further Reading

• Five stocks we like better than Bionik Laboratories
• Microsoft Just Flipped the AI Spending Narrative Overnight
• Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
• Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
• Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes

Receive News & Ratings for Bionik Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionik Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.